Sofosbuvir/Velpatasvir Fixed-Dose Combination in HCV-Infected Adults Who Are Undergoing Liver Transplantation
Clinical trial NCT02728206 · COMPLETED
Trial details
- NCT number
- NCT02728206
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-12
- Primary completion
- 2018-01-16
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.